- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, May 10, 2024
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
An article from Memory Care Business referenced a review published in a September 2022 supplement to The American Journal of Managed Care® (AJMC®) focusing on advancing Alzheimer disease treatment. The supplement article, “The Economic and Societal Burden of Alzheimer Disease: Managed Care Considerations,” highlighted that Alzheimer disease treatment could cost an estimated $321 billion in 2022, with costs expected to increase to $1 trillion in 2050.
An article from Business A.M. referenced a contributor article published on AJMC.com, the website of AJMC. The article, “Contributor: In the Misdiagnosis of Menopause, What Needs to Change?” highlighted that 80% of medical residents felt barely comfortable discussing menopause and only 20% of residency programs for obstetrics and gynecology offered menopause training.
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Rare Autoimmune Disorder Linked With Increased Risk of Certain Skin Cancers
April 21st 2025The risk of some skin cancers, including squamous cell carcinoma, basal cell carcinoma, and non-melanoma skin cancer, was particularly heightened among patients with severe mucous membrane pemphigoid.
Read More
